Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis

被引:46
|
作者
Karagiannidis C. [1 ]
Strassmann S. [1 ]
Brodie D. [2 ]
Ritter P. [3 ]
Larsson A. [4 ]
Borchardt R. [3 ]
Windisch W. [1 ]
机构
[1] Department of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO Centre, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University Hospital, Ostmerheimer Strasse 200, Cologne
[2] Division of Pulmonary, Allergy and Critical Care, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York City, NY
[3] Enmodes GmbH, Aachen
[4] Hedenstierna Laboratory, Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala
关键词
Asthma; ECCO[!sub]2[!/sub]R; ECMO; Exacerbation; Low-flow; Renal replacement therapy; Severe COPD;
D O I
10.1186/s40635-017-0147-0
中图分类号
学科分类号
摘要
Background: Veno-venous extracorporeal CO2 removal (vv-ECCO2R) is increasingly being used in the setting of acute respiratory failure. Blood flow rates through the device range from 200 ml/min to more than 1500 ml/min, and the membrane surface areas range from 0.35 to 1.3 m2. The present study in an animal model with similar CO2 production as an adult patient was aimed at determining the optimal membrane lung surface area and technical requirements for successful vv-ECCO2R. Methods: Four different membrane lungs, with varying lung surface areas of 0.4, 0.8, 1.0, and 1.3m2 were used to perform vv-ECCO2R in seven anesthetized, mechanically ventilated, pigs with experimentally induced severe respiratory acidosis (pH 7.0–7.1) using a 20Fr double-lumen catheter with a sweep gas flow rate of 8 L/min. During each experiment, the blood flow was increased stepwise from 250 to 1000 ml/min. Results: Amelioration of severe respiratory acidosis was only feasible when blood flow rates from 750 to 1000 ml/min were used with a membrane lung surface area of at least 0.8 m2. Maximal CO2 elimination was 150.8 ml/min, with pH increasing from 7.01 to 7.30 (blood flow 1000 ml/min; membrane lung 1.3 m2). The membrane lung with a surface of 0.4 m2 allowed a maximum CO2 elimination rate of 71.7 mL/min, which did not result in the normalization of pH, even with a blood flow rate of 1000 ml/min. Also of note, an increase of the surface area above 1.0 m2 did not result in substantially higher CO2 elimination rates. The pressure drop across the oxygenator was considerably lower (<10 mmHg) in the largest membrane lung, whereas the smallest revealed a pressure drop of more than 50 mmHg with 1000 ml blood flow/min. Conclusions: In this porcine model, vv-ECCO2R was most effective when using blood flow rates ranging between 750 and 1000 ml/min, with a membrane lung surface of at least 0.8 m2. In contrast, low blood flow rates (250–500 ml/min) were not sufficient to completely correct severe respiratory acidosis, irrespective of the surface area of the membrane lung being used. The converse was also true, low surface membrane lungs (0.4 m2) were not capable of completely correcting severe respiratory acidosis across the range of blood flows used in this study. © 2017, The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis
    Cove, Matthew E.
    Federspiel, William J.
    CRITICAL CARE, 2015, 19
  • [2] Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis
    Matthew E Cove
    William J Federspiel
    Critical Care, 19
  • [3] Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis Response
    Karagiannidis, Christian
    Windisch, Wolfram
    Mueller, Thomas
    CRITICAL CARE, 2015, 19
  • [4] Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations
    Karagiannidis, Christian
    Kampe, Kristin Aufm
    Suarez Sipmann, Fernando
    Larsson, Anders
    Hedenstierna, Goran
    Windisch, Wolfram
    Mueller, Thomas
    CRITICAL CARE, 2014, 18 (03):
  • [5] Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations
    Christian Karagiannidis
    Kristin Aufm Kampe
    Fernando Suarez Sipmann
    Anders Larsson
    Goran Hedenstierna
    Wolfram Windisch
    Thomas Mueller
    Critical Care, 18
  • [6] Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure
    Zwischenberger, JB
    Conrad, SA
    Alpard, SK
    Grier, LR
    Bidani, A
    ANNALS OF THORACIC SURGERY, 1999, 68 (01): : 181 - 187
  • [7] Severe Lung Dysfunction and Pulmonary Blood Flow during Extracorporeal Membrane Oxygenation
    Falk, Lars
    Lidegran, Marika
    Ruiz, Sandra Diaz
    Hultman, Jan
    Broman, Lars Mikael
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [8] Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure -: Discussion
    Graeber, GM
    Zwischenberger, JB
    ANNALS OF THORACIC SURGERY, 1999, 68 (01): : 187 - 187
  • [10] EXTRACORPOREAL CO2 REMOVAL IN A LUNG LAVAGE MODEL OF RESPIRATORY-FAILURE
    MANCINI, P
    WHITTLESEY, GC
    SALLEY, SO
    KLEIN, MD
    JOURNAL OF PEDIATRIC SURGERY, 1994, 29 (08) : 1127 - 1129